西洛多辛治疗后可能出现的黏膜固定性药疹病例
A Probable Case of Mucosal Fixed Drug Eruption Following Treatment with Silodosin.
作者信息
Klimi Eleni
机构信息
Department of Dermatology, Thriasio General Hospital, Athens, Greece.
出版信息
Sultan Qaboos Univ Med J. 2018 Aug;18(3):e402-e404. doi: 10.18295/squmj.2018.18.03.025. Epub 2018 Dec 19.
Abstract
A fixed drug eruption consists of erythematous patches that appear on the skin and/or mucous membranes following administration of a drug which, once healed, leaves residual hyperpigmentation. We report a 76-year-old male who presented to the Thriasio General Hospital, Athens, Greece, in 2016 with erythema, oedema and blistering of the lower lip and penis following the administration of silodosin for benign prostatic hyperplasia. The eruption regressed two weeks after silodosin was discontinued.
摘要
固定性药疹表现为在使用某种药物后出现在皮肤和/或黏膜上的红斑性斑片，一旦愈合，会留下色素沉着。我们报告一例76岁男性，2016年因良性前列腺增生服用西洛多辛后，出现下唇和阴茎的红斑、水肿及水疱，就诊于希腊雅典的特里亚西奥综合医院。停用西洛多辛两周后皮疹消退。
相似文献
1
A Probable Case of Mucosal Fixed Drug Eruption Following Treatment with Silodosin.西洛多辛治疗后可能出现的黏膜固定性药疹病例
Sultan Qaboos Univ Med J. 2018 Aug;18(3):e402-e404. doi: 10.18295/squmj.2018.18.03.025. Epub 2018 Dec 19.
2
Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.西洛多辛与盐酸坦索罗辛交叉治疗良性前列腺增生相关下尿路症状的短期疗效。
Int J Urol. 2010 Oct;17(10):869-75. doi: 10.1111/j.1442-2042.2010.02614.x. Epub 2010 Aug 24.
3
Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia.射精障碍与西洛多辛治疗良性前列腺增生的疗效增加有关。
Urology. 2010 Dec;76(6):1446-50. doi: 10.1016/j.urology.2010.03.015. Epub 2010 May 15.
4
Silodosin for benign prostatic hyperplasia.西洛多辛治疗良性前列腺增生。
Ann Pharmacother. 2010 Feb;44(2):302-10. doi: 10.1345/aph.1M320. Epub 2010 Jan 13.
5
Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.西洛多辛，一种用于治疗良性前列腺增生的新型α1A肾上腺素能受体选择性拮抗剂：在日本男性中进行的III期随机、安慰剂对照、双盲研究结果
BJU Int. 2006 Nov;98(5):1019-24. doi: 10.1111/j.1464-410X.2006.06448.x. Epub 2006 Aug 31.
6
Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia.西洛多辛：用于治疗良性前列腺增生的选择性 α1A-肾上腺素能受体拮抗剂。
Clin Ther. 2009 Nov;31(11):2489-502. doi: 10.1016/j.clinthera.2009.11.024.
7
Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.西洛多辛治疗良性前列腺增生：药理学和心血管耐受性。
Pharmacotherapy. 2010 Dec;30(12):1303-12. doi: 10.1592/phco.30.12.1303.
8
[Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia].
Hinyokika Kiyo. 2008 Dec;54(12):757-64.
9
Editorial comment to short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Int J Urol. 2010 Oct;17(10):875. doi: 10.1111/j.1442-2042.2010.02624.x.
10
Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study.西洛多辛治疗良性前列腺增生症的症状：一项 9 个月、开放标签延伸研究。
Urology. 2009 Dec;74(6):1318-22. doi: 10.1016/j.urology.2009.06.072. Epub 2009 Oct 7.
本文引用的文献
1
Mucosal fixed drug eruption due to mefenamic acid: Report of a case and a review.甲芬那酸引起的黏膜固定性药疹：1例报告及文献复习
Therapie. 2018 Oct;73(5):433-435. doi: 10.1016/j.therap.2018.01.005. Epub 2018 Feb 15.
2
Generalized bullous fixed drug eruption imitating toxic epidermal necrolysis: a case report and literature review.酷似中毒性表皮坏死松解症的泛发性大疱性固定型药疹：1例报告及文献复习
Dermatol Online J. 2017 Jul 15;23(7):13030/qt25v009gs.
3
Causality assessment in pharmacovigilance: The French method and its successive updates.药物警戒中的因果关系评估：法国方法及其后续更新
Therapie. 2016 Apr;71(2):179-86. doi: 10.1016/j.therap.2016.02.010. Epub 2016 Feb 6.
4
Maculopapular type drug eruption caused by silodosin.西洛多辛引起的斑丘疹型药疹。
Allergol Int. 2016 Apr;65(2):219-220. doi: 10.1016/j.alit.2015.11.008. Epub 2016 Jan 21.
5
Adverse cutaneous drug eruptions: current understanding.药物性皮肤不良反应：当前的认识
Semin Immunopathol. 2016 Jan;38(1):75-86. doi: 10.1007/s00281-015-0540-2. Epub 2015 Nov 9.
6
Silodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia.西洛多辛：治疗良性前列腺增生症的体征和症状的应用评价。
Drugs. 2015 Feb;75(2):207-17. doi: 10.1007/s40265-014-0344-z.
7
Fixed drug eruptions: presentation, diagnosis, and management.固定性药疹：临床表现、诊断与治疗
South Med J. 2014 Nov;107(11):724-7. doi: 10.14423/SMJ.0000000000000195.
8
Meprobamate-induced fixed drug eruption.眠尔通引起的固定性药疹。
Curr Drug Saf. 2014;9(2):161-2. doi: 10.2174/1574886309666140121105737.
9
Fixed drug eruption: the dark side of activation of intraepidermal CD8+ T cells uniquely specialized to mediate protective immunity.固定性药疹：介导保护性免疫的表皮内CD8 + T细胞活化的阴暗面。
Chem Immunol Allergy. 2012;97:106-21. doi: 10.1159/000335623. Epub 2012 May 3.
10
Pseudoephedrine may cause "pigmenting" fixed drug eruption.伪麻黄碱可能引起“色素沉着”固定型药物疹。
Dermatitis. 2011 May;22(3):E7-9.
Zotero 插件